New Jersey Intellectual Property Cases
Cases 131 - 140 of 762
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2023cv01369
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2023cv01369
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
ADVERIO PHARMA GMBH et al v. ALEMBIC PHARMACEUTICALS LIMITED et al
as 2:2023cv01285
Plaintiff:
ADVERIO PHARMA GMBH, BAYER AG and BAYER HEALTHCARE PHARMACEUTICALS INC.
Defendant:
ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC GLOBAL HOLDING SA and ALEMBIC PHARMACEUTICLAS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEXUS PHARMACEUTICALS, INC. v. SOMERSET PHARMA, LLC
as 3:2023cv01248
Plaintiff:
NEXUS PHARMACEUTICALS, INC.
Defendant:
SOMERSET PHARMA, LLC and SOMERSET THERAPEUTICS, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ASTELLAS PHARMA INC. et al v. SANDOZ, INC.
as 2:2023cv01214
Plaintiff:
ASTELLAS PHARMA INC., ASTELLAS US LLC and ASTELLAS PHARMA US, INC.
Defendant:
SANDOZ, INC. and PHV ELIZABETH M. FLANAGAN
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ASTELLAS PHARMA INC. et al v. SANDOZ, INC.
as 3:2023cv01214
Plaintiff:
ASTELLAS PHARMA INC., ASTELLAS US LLC and ASTELLAS PHARMA US, INC.
Defendant:
SANDOZ, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CATALYST PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS, INC. et al
as 2:2023cv01190
Counter Defendant:
CATALYST PHARMACEUTICALS, INC. and SERB SA
Counter Claimant:
TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CATALYST PHARMACEUTICALS, INC. et al v. LUPIN LTD. et al
as 2:2023cv01197
Plaintiff:
CATALYST PHARMACEUTICALS, INC. and SERB SA
Defendant:
LUPIN LTD., LUPIN INC. and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CATALYST PHARMACEUTICALS, INC. et al v. ANNORA PHARMA PRIVATE LIMITED et al
as 2:2023cv01194
Plaintiff:
CATALYST PHARMACEUTICALS, INC. and SERB SA
Defendant:
ANNORA PHARMA PRIVATE LIMITED, GRACE CONSULTING SERVICES, INC., HETERO LABS LIMITED and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 2:2023cv01150
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
